The Lancet Oncology · 2015 · 943 citations · 17 references
MedicineOncologyPharmacologyCancer PharmacologyMetastasisUrologic OncologyKidney CancerMalignant NeoplasmsMetastatic Disease TreatmentMetastatic Urologic CancerRenal Cell CarcinomaRenal NeoplasmsEverolimus TreatmentEverolimus-based RegimensMetastatic Kidney CancerMetastatic Renal Cell Carcinoma TherapyRenal Malignancy
17
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Bernard Escudier, Camillo Porta, Manuela Schmidinger et al. · Annals of Oncology · 2014 · 2.3K citations · Full text
Medicine, Nephrology, Oncology +14
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger, Makoto Tahara, Lori J. Wirth et al. · New England Journal of Medicine · 2015 · 2.1K citations · Full text
Phase 3 trial of everolimus for metastatic renal cell carcinoma
Robert J. Motzer, Bernard Escudier, Stéphane Oudard et al. · Cancer · 2010 · 1.1K citations
Medicine, Oncology, Pharmacology +17
Robert J. Motzer, Bernard Escudier, Piotr Tomczak et al. · The Lancet Oncology · 2013 · 745 citations
Medicine, Oncology, Pharmacology +10